Citation: Sun Chang'an, Fang Lei, Gou Shaohua. Discovery of a Novel FGFR4 Selective Inhibitor via Structure-Activity Relationship Studies of FGF401[J]. Chinese Journal of Organic Chemistry, ;2020, 40(1): 84-94. doi: 10.6023/cjoc201904073 shu

Discovery of a Novel FGFR4 Selective Inhibitor via Structure-Activity Relationship Studies of FGF401

Jiangsu Province Hi-Tech Key Laboratory for Bio-medical Research and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189

Corresponding author: Fang Lei, lei.fang@seu.edu.cn Gou Shaohua, sgou@seu.edu.cn
Received Date: 29 April 2019
Revised Date: 31 August 2019
Available Online: 18 January 2019
Fund Project: the National Science and Technology Major Foundation of China 2013ZX09402102-001-006Project supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. 1107047002) and the National Science and Technology Major Foundation of China (No. 2013ZX09402102-001-006)the Priority Academic Program Development of Jiangsu Higher Education Institutions 1107047002

Figures(3)

A set of analogues of FRF401 were designed and synthesized, and their FGFR4 inhibition and antitumor activity as well as the structure-activity relationship (SAR) studies were screened. It was found that N-(5-cyano-4-((2-methoxyethyl)-amino)pyridin-2-yl)-7-formyl-6-((N-methyltetrahydro-2H-pyran-4-carboxamido)methyl)-1, 2, 3, 4-tetrahydro-1, 8-naphthyridine-1-carboxamide (8ac) not only showed superior FGFR4 inhibitory activity compared with FGF401 and excellent selectivity in enzymatic and cellular level, but also dramatically inhibited tumor growth and induced tumor regression in hepatocellular carcinoma xenograft model.
- selective FGFR4 inhibitor,
- analogues of FRF401,
- structure-activity relationship,
- hepatocellular carcinoma
1. [1]
  Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R. L.; Torre L. A.; Jemal A. CA: Cancer J. Clin. 2018, 68, 394.
2. [2]
  Keating, G. M.; Santoro, A. Drugs 2009, 69, 223. doi: 10.2165/00003495-200969020-00006
3. [3]
  US Food and Drug Administration Approved Drugs-FDA Approves Lenvatinib for Unresectable Hepatocellular Carcinoma, Published Online: Aug 16, 2018. https://www.fda.gov/drugs/resources-infor-mation-approved-drugs/fda-approves-lenvatinib-unresectable-hepa-tocellular-carcinoma(accessed Jan 19, 2020).
4. [4]
  Ho, H. K.; Pok, S.; Streit, S.; Ruhe, J. E.; Hart, S.; Lim, K. S.; Loo, H. L.; Aung, M. O.; Lim, S. G.; Ullrich, A. J. Hepatol. 2009, 50, 118. doi: 10.1016/j.jhep.2008.08.015
5. [5]
  Sawey, E. T.; Chanrion, M.; Cai, C. L.; Wu, G. M.; Zhang, J. P.; Zender, L.; Zhao, A.; Busuttil, R. W.; Yee, H. M.; Stein, L.; French, D. M.; Finn, R. S.; Lowe, S. W.; Powers, S. Cancer Cell 2011, 19, 347. doi: 10.1016/j.ccr.2011.01.040
6. [6]
  Hyeon, J.; Ahn, S.; Lee, J. J.; Song, D. H.; Park, C. K. Dig. Dis. Sci. 2013, 58, 1916. doi: 10.1007/s10620-013-2609-x
7. [7]
  Pinyol, R.; Nault, J. C.; Quetglas, I. M.; Zucman-Rossi, J.; Llovet, J. M. Semin. Liver Dis. 2014, 34, 363. doi: 10.1055/s-0034-1394137
8. [8]
  Tucker, J. A.; Klein, T.; Breed, J.; Overman, R.; Phillips, C.; Norman, R. A. Structure 2014, 22, 1764. doi: 10.1016/j.str.2014.09.019
9. [9]
  Llovet, J. M.; Villanueva, A.; Lachenmayer, A.; Finn, R. S. Nat. Rev. Clin. Oncol. 2015, 12, 408. doi: 10.1038/nrclinonc.2015.103
10. [10]
  Repana, D.; Ross, P. Diseases 2015, 3, 294. doi: 10.3390/diseases3040294
11. [11]
  Lu, X. Y.; Chen, H.; Patterson, A. V.; Smaill, J. B.; Ding, K. J. Med. Chem. 2019, 62, 2905. doi: 10.1021/acs.jmedchem.8b01531
12. [12]
  Hagel, M.; Miduturu, C.; Sheets, M.; Rubin, N.; Weng, W.; Stransky, N.; Bifulco, N.; Kim, J. L.; Hodous, B.; Brooijmans, N.; Shutes, A.; Winter, C.; Lengauer, C.; Kohl, N. E.; Guzi, T. Cancer Discovery 2015, 5, 424. doi: 10.1158/2159-8290.CD-14-1029
13. [13]
  Joshi, J. J.; Coffey, H.; Corcoran, E.; Tsai, J.; Huang, C. L.; Ichikawa, K.; Prajapati, S.; Hao, M. H.; Bailey, S.; Wu, J. Cancer Res. 2017, 77, 6999. doi: 10.1158/0008-5472.CAN-17-1865
14. [14]
  Mo, C.; Zhang, Z.; Guise, C. P.; Li, X.; Luo, J.; Tu, Z.; Xu, Y.; Patterson, A. V.; Smaill, J. B.; Ren, X. ACS Med. Chem. Lett. 2017, 8, 543. doi: 10.1021/acsmedchemlett.7b00091
15. [15]
  Wang, Y.; Chen, Z.; Dai, M.; Sun, P.; Wang, C.; Gao, Y.; Zhao, H.; Zeng, W.; Shen, L.; Mao, W. Bioorg Med. Chem. Lett. 2017, 27, 2420. doi: 10.1016/j.bmcl.2017.04.014
16. [16]
  Knoepfel, T.; Furet, P.; Mah, R.; Buschmann, N.; Leblanc, C.; Ripoche, S.; Graus-Porta, D.; Wartmann, M.; Galuba, I.; Fairhurst, R. A. ACS Med. Chem. Lett. 2018, 9, 215. doi: 10.1021/acsmedchemlett.7b00485
17. [17]
  Yasuda, N.; Hsiao, Y.; Jensen, M. S.; Rivera, N. R.; Yang, C. H.; Wells, K. M.; Yau, J.; Palucki, M.; Tan, L. S.; Dormer, P. G.; Volante, R. P.; Hughes, D. L.; Reider, P. J. J. Org. Chem. 2004, 69, 1959. doi: 10.1021/jo030297u
18. [18]
  Novartis, A. G.; Buschmann, N.; Fairhurst, R. A.; Furet, P.; Knöpfel, T.; Leblanc, C.; Liao, L.; Wang, C.; Zhao, X. L. US 2015/119385, 2015.
1. [1]
  Jinyu Guo , Yandai Lin , Shaohua He , Yueqing Chen , Fenglu Li , Renjie Ruan , Gaoxing Pan , Hexin Nan , Jibin Song , Jin Zhang . Utilizing dual-responsive iridium(Ⅲ) complex for hepatocellular carcinoma: Integrating photoacoustic imaging with chemotherapy and photodynamic therapy. Chinese Chemical Letters, 2024, 35(9): 109537-. doi: 10.1016/j.cclet.2024.109537
2. [2]
  Zhiyu Yu , Xiang Luo , Cheng Zhang , Xin Lu , Xiaohui Li , Pan Liao , Zhongqiu Liu , Rong Zhang , Shengtao Wang , Zhiqiang Yu , Guochao Liao . Mitochondria-targeted carrier-free nanoparticles based on dihydroartemisinin against hepatocellular carcinoma. Chinese Chemical Letters, 2024, 35(10): 109519-. doi: 10.1016/j.cclet.2024.109519
3. [3]
  Qiuye Wang , Yabing Sun , Liangxue Lai , Haijing Cui , Yonglong Ye , Ming Yang , Weihao Zhu , Bo Yuan , Quanliang Mao , Wenzhi Ren , Aiguo Wu . MMP-9-responsive probe for fluorescence-magnetic resonance dual-mode imaging of hepatocellular carcinoma models with different metastatic capacities. Chinese Chemical Letters, 2025, 36(4): 110212-. doi: 10.1016/j.cclet.2024.110212
4. [4]
  Zhihao HE , Jiafu DING , Yunjie WANG , Xin SU . First-principles study on the structure-property relationship of AlX and InX (X=N, P, As, Sb). Chinese Journal of Inorganic Chemistry, 2025, 41(5): 1007-1019. doi: 10.11862/CJIC.20240390
5. [5]
  Jia Chen , Yun Liu , Zerong Long , Yan Li , Hongdeng Qiu . Colorimetric detection of α-glucosidase activity using Ni-CeO₂ nanorods and its application to potential natural inhibitor screening. Chinese Chemical Letters, 2024, 35(9): 109463-. doi: 10.1016/j.cclet.2023.109463
6. [6]
  Yao HUANG , Yingshu WU , Zhichun BAO , Yue HUANG , Shangfeng TANG , Ruixue LIU , Yancheng LIU , Hong LIANG . Copper complexes of anthrahydrazone bearing pyridyl side chain: Synthesis, crystal structure, anticancer activity, and DNA binding. Chinese Journal of Inorganic Chemistry, 2025, 41(1): 213-224. doi: 10.11862/CJIC.20240359
7. [7]
  Jia JI , Zhaoyang GUO , Wenni LEI , Jiawei ZHENG , Haorong QIN , Jiahong YAN , Yinling HOU , Xiaoyan XIN , Wenmin WANG . Two dinuclear Gd(Ⅲ)-based complexes constructed by a multidentate diacylhydrazone ligand: Crystal structure, magnetocaloric effect, and biological activity. Chinese Journal of Inorganic Chemistry, 2025, 41(4): 761-772. doi: 10.11862/CJIC.20240344
8. [8]
  Zhexin Chen , Yuqing Shi , Fang Zhong , Kai Zhang , Furong Zhang , Shenghong Xie , Zhongbin Cheng , Qian Zhou , Yi-You Huang , Hai-Bin Luo . Discovery of amentoflavone as a natural PDE4 inhibitor with anti-fibrotic effects. Chinese Chemical Letters, 2025, 36(4): 109956-. doi: 10.1016/j.cclet.2024.109956
9. [9]
  Jian Song , Shenghui Wang , Qiuge Liu , Xiao Wang , Shuo Yuan , Hongmin Liu , Saiyang Zhang . N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations. Chinese Chemical Letters, 2025, 36(2): 109678-. doi: 10.1016/j.cclet.2024.109678
10. [10]
  Ke Gong , Jinghan Liao , Jiangtao Lin , Quan Wang , Zhihua Wu , Liting Wang , Jiali Zhang , Yi Dong , Yourong Duan , Jianhua Chen . Mitochondria-targeted nanoparticles overcome chemoresistance via downregulating BACH1/CD47 axis in ovarian carcinoma. Chinese Chemical Letters, 2024, 35(5): 108888-. doi: 10.1016/j.cclet.2023.108888
11. [11]
  Jiechen Liu , Xiaoguang Li , Ruiyang Xia , Yuqi Wang , Fenghe Zhang , Yongzhi Pang , Qing Li . Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109619-. doi: 10.1016/j.cclet.2024.109619
12. [12]
  Yanye Fan , Jingjing Chen , Bichun Chen , Jinyu Bai , Bowen Yang , Feng Liang , Lijing Fang . Design, synthesis and biological evaluation of Leu₁₀-teixobactin analogues. Chinese Chemical Letters, 2025, 36(4): 110075-. doi: 10.1016/j.cclet.2024.110075
13. [13]
  Liang Ma , Zhou Li , Zhiqiang Jiang , Xiaofeng Wu , Shixin Chang , Sónia A. C. Carabineiro , Kangle Lv . Effect of precursors on the structure and photocatalytic performance of g-C3N4 for NO oxidation and CO2 reduction. Chinese Journal of Structural Chemistry, 2024, 43(11): 100416-100416. doi: 10.1016/j.cjsc.2024.100416
14. [14]
  Hailang Deng , Abebe Reda Woldu , Abdul Qayum , Zanling Huang , Weiwei Zhu , Xiang Peng , Paul K. Chu , Liangsheng Hu . Killing two birds with one stone: Enhancing the photoelectrochemical water splitting activity and stability of BiVO₄ by Fe ions association. Chinese Chemical Letters, 2024, 35(12): 109892-. doi: 10.1016/j.cclet.2024.109892
15. [15]
  Gang Hu , Chun Wang , Qinqin Wang , Mingyuan Zhu , Lihua Kang . The controlled oxidation states of the H₄PMo₁₁VO₄₀ catalyst induced by plasma for the selective oxidation of methacrolein. Chinese Chemical Letters, 2025, 36(2): 110298-. doi: 10.1016/j.cclet.2024.110298
16. [16]
  Yu BAI , Jijiang WANG , Long TANG , Erlin YUE , Chao BAI , Xiao WANG , Yuqi ZHANG . A cadmium(Ⅱ) coordination polymer based on a semirigid tetracarboxylate ligand for highly selective detection of Fe³⁺ and 4-nitrophenol. Chinese Journal of Inorganic Chemistry, 2025, 41(6): 1217-1226. doi: 10.11862/CJIC.20240457
17. [17]
  Lu LIU , Huijie WANG , Haitong WANG , Ying LI . Crystal structure of a two-dimensional Cd(Ⅱ) complex and its fluorescence recognition of p-nitrophenol, tetracycline, 2, 6-dichloro-4-nitroaniline. Chinese Journal of Inorganic Chemistry, 2024, 40(6): 1180-1188. doi: 10.11862/CJIC.20230489
18. [18]
  Xianchen Hu , Junli Yang , Fang Gao , Zhiyong Zhao , Simin Liu . Highly selective [4+4] cross-photodimerization of (4a-azonia)anthracenes driven by confinement of D-A hetero-guest pair in cucurbit[10]uril host. Chinese Chemical Letters, 2025, 36(3): 109967-. doi: 10.1016/j.cclet.2024.109967
19. [19]
  Yuwei Liu , Yihui Zhu , Weijian Duan , Yizhuo Yang , Haorui Tuo , Chunhua Feng . Electrocatalytic nitrate reduction on Fe, Fe₃O₄, and Fe@Fe₃O₄ cathodes: Elucidating structure-sensitive mechanisms of direct electron versus hydrogen atom transfer. Chinese Chemical Letters, 2025, 36(6): 110347-. doi: 10.1016/j.cclet.2024.110347
20. [20]
  Chaozheng He , Pei Shi , Donglin Pang , Zhanying Zhang , Long Lin , Yingchun Ding . First-principles study of the relationship between the formation of single atom catalysts and lattice thermal conductivity. Chinese Chemical Letters, 2024, 35(6): 109116-. doi: 10.1016/j.cclet.2023.109116

Get Citation

PDF

XML

Metrics

PDF Downloads(4)
Abstract views(612)
HTML views(38)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142